Reliability of Visual Field Index in Staging Glaucomatous Visual Field Damage
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 6
Abstract
ABSTRACT Introduction: Standard automated perimetry is integral to the testing of visual function in glaucoma. Classification of glaucomatous visual field defects into different severity levels is important to guide effective management; but the available classification systems may be cumbersome and impractical on a daily basis. Aim: To quantify, correlate and analyse the relation between Visual Field Index (VFI) and the stages of glaucomatous field damage as defined by Hodapp Parrish Anderson (HPA). To check the validity of Glaucoma Staging Indices (GSI), which is a new glaucomatous field classification system dependent on VFI. Materials and Methods: The study was a prospective, observational analysis of consecutive visual field tests done between August 2015 and March 2016. The Institutional Ethical Committee approved the protocol, and participants who gave written informed consent were included in the study. Patients underwent a comprehensive eye examination including standard automated perimetry with Humphrey Visual Field Analyser. Data was collected from each visual field and the fields were evaluated and classified into four stages- Normal, Early defect, Moderate defect or Severe defect based on HPA classification. HPA and Geological Strength Index (GSI) classification systems were compared and analysed with Kappa analysis. Results: Analysis of 170 visual fields of 95 patients showed that VFI was significantly different between Normal, Early defect, Moderate defect and Severe defects as classified with HPA staging, p<0.001. VFI had strong positive correlation with Mean Deviation (MD), r=0.984, p<0.001 and non-linear correlation with Pattern Standard Deviation (PSD), r = -0.472, p<0.001. On comparing HPA staging with GSI, κ=0.633, p<0.001. VFI, MD and PSD in each of the severity stages across the two classification systems showed no significant differences (p>0.05). Conclusion: In established glaucoma, GSI is a good dependable staging system. It is readily available on the single field print out and can be a quick reference for decision making in the management of glaucoma patients.
Authors and Affiliations
Neetha Kuzhuppilly, Shilpa Patil, Shibi Dev, Aditya Deo
Keywords
Related Articles
- EP ID EP524021
- DOI 10.7860/JCDR/2018/34541.11620
- Views 58
- Downloads 0
Standardization and Quality Improvement of Laboratory Services in India: Need and Challenges
Abstract Quality is a subjective term – subjective with respect to individual and time. Quality concepts were introduced and implemented by industry during world war II. In health care system, these concepts were introdu...
Idiopathic Unilateral Gynaecomastia in Prepubertal Age: A Rare Presentation and Review of Literature
ABSTRACT Unilateral idiopathic gynaecomastia of prepurtal age is a rare presentation. Complete evaluation of unilateral gynaecomastia should be done to identify etiology. We managed a case of unilateral gynaecomastia in...
A Histo-Morphological Study of Changes in Neoadjuvant Chemotherapy in Breast Malignancies
ABSTRACT Introduction: The administration of systemic chemotherapy in order to shrink the size of the tumour before surgical resection is termed as Neoadjuvant Chemotherapy (NACT) and has been shown to improve the overal...
Single-Dose Oral Dexamethasone Compared with Three Day Course of Oral Prednisolone in Children with Moderate Exacerbation of Asthma-A Pilot Double-Blinded Randomised Controlled Trial
Abstract Introduction: Corticosteroids are the mainstay of treatment for a child with acute exacerbation of asthma. Though, several guidelines suggest use of prednisolone for few days, recently single dose dexamethasone...
Association of Androgen Receptor (AR) CAG Repeats and Cytochrome P450 3A5*3 (CYP3A5*3) Gene Polymorphisms in South Indian Men with Prostate Cancer
ABSTRACT Introduction: Prostate Cancer (PCA) is the second most common cancer diagnosed in men worldwide. Prostate Specific Antigen (PSA) is the readily used biomarker for PCA screening, but lack of specificity limits it...